India  /  Published 24.11.20

India inches closer to coronavirus vaccine

The company said it would seek emergency use listing from the World Health Organisation for an accelerated pathway to make the vaccine available in low-income countries and “immediately prepare&...
By G.S. Mudur, Reuters in New Delhi

Business  /  Published 23.11.20

G20: vaccine pledge

Leaders of the 20 biggest economies on Sunday vowed to spare no effort to supply Covid-19 drugs, tests and vaccines affordably and fairly to “all people”, reflecting worries that the pande...
By Reuters in Riyadh, Dubai

West Bengal  /  Published 23.11.20

Mamata to attend PM’s vaccine meet

Chief minister Mamata Banerjee will join a videoconference meeting on Tuesday that Prime Minister Narendra Modi will hold with the chief ministers of several states to discuss infrastructure needed fo...
By Pranesh Sarkar in Calcutta

India  /  Published 22.11.20

Vaccine: Govt mulls early approvals

The Centre is exploring modalities of providing emergency authorisation and license to use Covid-19 vaccines pending phase III clinical trials and regular licensure. In a recent meeting attended by N...
By Our Bureau, Agencies in New Delhi

India  /  Published 20.11.20

Covaxin dose administered on Haryana minister

Haryana health minister Anil Vij on Friday was administered a trial dose of indigenously made potential coronavirus vaccine, Covaxin, at Ambala, as he became the first volunteer in the state to receiv...
By Our Bureau, Agencies in Ambala

India  /  Published 20.11.20

First signs of immunity without a vaccine

Medical researchers have documented for the first time in India fewer new cases of the coronavirus disease in urban areas with large proportions of previously infected people, a sign of emerging popul...
By G.S. Mudur in New Delhi

World  /  Published 20.11.20

Oxford trials are ‘encouraging’

AstraZeneca and Oxford University’s potential Covid-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-st...
By Reuters in

India  /  Published 19.11.20

Vaccine boost and rider

By G.S. Mudur in New Delhi

World  /  Published 18.11.20

Vaccine: Pfizer nearing nod

Global drugmakers Pfizer and BioNTech on Wednesday said they have concluded phase 3 study of their mRNA-based Covid-19 vaccine candidate with 95 per cent efficacy rate, adding that they...
By Agencies in

India  /  Published 18.11.20

India's hopes hinge on vaccines on trial at home

By G.S. Mudur in New Delhi


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.